TY - JOUR
T1 - De novo p.G696S mutation in COL4A1 causes intracranial calcification and late-onset cerebral hemorrhage
T2 - A case report and review of the literature COL4A1-associated vasculopathy
AU - Kinoshita, Keishiro
AU - Ishizaki, Yoshito
AU - Yamamoto, Hiroyuki
AU - Sonoda, Motoshi
AU - Yonemoto, Kousuke
AU - Kira, Ryutaro
AU - Sanefuji, Masafumi
AU - Ueda, Akihiko
AU - Matsui, Hirotaka
AU - Ando, Yukio
AU - Sakai, Yasunari
AU - Ohga, Shouichi
N1 - Funding Information:
We thank Ms Tamami Tanaka PhD and Ms Ayumi Tahara for technical assistance, and all the lab members in our department for helpful discussion. This work was supported by JSPS Kakenhi grant number 17K16271 (YI) and 19K08281 (YS) , a Health and Labour Sciences Research Grant on Evidence-based Early Diagnosis and Treatment Strategies for Neuroimmunological Diseases from the Ministry of Health, Labour and Welfare of Japan , and Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (YS). Appendix A
Funding Information:
We thank Ms Tamami Tanaka PhD and Ms Ayumi Tahara for technical assistance, and all the lab members in our department for helpful discussion. This work was supported by JSPS Kakenhi grant number 17K16271 (YI) and 19K08281 (YS), a Health and Labour Sciences Research Grant on Evidence-based Early Diagnosis and Treatment Strategies for Neuroimmunological Diseases from the Ministry of Health, Labour and Welfare of Japan, and Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (YS).
Publisher Copyright:
© 2019 Elsevier Masson SAS
PY - 2020/4
Y1 - 2020/4
N2 - Background: The collagen type IV alpha 1 chain (COL4A1) is an essential component of the basement membrane in small vessels. Pathogenic variants in COL4A1 cause perinatal cerebral hemorrhages in an autosomal-dominant fashion. However, little is known about the long-term outcomes of patients with mildly affecting COL4A1 mutations. Case report: We report a 17-year-old boy, who presented with recurrent intracranial hemorrhages in the periventricular white matter. He had been followed-up as a child with cerebral palsy bearing intracranial calcifications, developmental delay and epilepsy. Screening tests in infancy provided negative results for intrauterine infections. Severe motor and cognitive deficits persisted after admission. Carbazochrome was introduced on day 19 of admission, which appeared to prevent extension and reactivation of cerebral hemorrhages for over 6 months after discharge. Results: Targeted sequencing of NOTCH3 and TREX1 excluded causal mutations in these genes. The whole-exome sequencing revealed that he carried a de novo mutation in COL4A1 (p.Gly696Ser). An overview of the literature for 345 cases with COL4A1 mutations supported evidence that p.Gly696Ser is associated with the unique phenotype of late-onset hemorrhage among patients with COL4A1-associated cerebral angiopathy. Conclusions: This case first demonstrates that infants with COL4A1-associated leukoencephalopathy and calcifications have a risk for developing the rupture of small vessels in the cerebral white matter after 10 years of age.
AB - Background: The collagen type IV alpha 1 chain (COL4A1) is an essential component of the basement membrane in small vessels. Pathogenic variants in COL4A1 cause perinatal cerebral hemorrhages in an autosomal-dominant fashion. However, little is known about the long-term outcomes of patients with mildly affecting COL4A1 mutations. Case report: We report a 17-year-old boy, who presented with recurrent intracranial hemorrhages in the periventricular white matter. He had been followed-up as a child with cerebral palsy bearing intracranial calcifications, developmental delay and epilepsy. Screening tests in infancy provided negative results for intrauterine infections. Severe motor and cognitive deficits persisted after admission. Carbazochrome was introduced on day 19 of admission, which appeared to prevent extension and reactivation of cerebral hemorrhages for over 6 months after discharge. Results: Targeted sequencing of NOTCH3 and TREX1 excluded causal mutations in these genes. The whole-exome sequencing revealed that he carried a de novo mutation in COL4A1 (p.Gly696Ser). An overview of the literature for 345 cases with COL4A1 mutations supported evidence that p.Gly696Ser is associated with the unique phenotype of late-onset hemorrhage among patients with COL4A1-associated cerebral angiopathy. Conclusions: This case first demonstrates that infants with COL4A1-associated leukoencephalopathy and calcifications have a risk for developing the rupture of small vessels in the cerebral white matter after 10 years of age.
UR - http://www.scopus.com/inward/record.url?scp=85077159647&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077159647&partnerID=8YFLogxK
U2 - 10.1016/j.ejmg.2019.103825
DO - 10.1016/j.ejmg.2019.103825
M3 - Article
C2 - 31857254
AN - SCOPUS:85077159647
SN - 1769-7212
VL - 63
JO - European Journal of Medical Genetics
JF - European Journal of Medical Genetics
IS - 4
M1 - 103825
ER -